XML 25 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Cash Flows - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2021
Jul. 31, 2020
Oct. 31, 2020
Oct. 31, 2019
Oct. 31, 2018
Operating activities              
Net loss for the year $ (6,897,318) $ (1,810,981) $ (21,590,783) $ (4,842,463) $ (9,275,962) $ (4,100,782) $ (908,869)
Items not affecting cash              
Share-based compensation 298,489 57,383 1,307,874 220,440 332,634 97,258 26,523
Depreciation 697,604 327,806 1,830,603 717,278 1,095,250 183,862 0
Amortization of government grants (26,887) (1,086,133) (92,926) (2,176,041) (2,226,910) (640,350) (77,215)
Loss on disposal of assets     13,399   106,946 0 0
FX (gain) loss on translation (152,562) 153,808 509,195 (451,238) (390,901) (33,845) 5,032
Share-based professional fees   455,055   455,055 455,055 0 0
Fair value loss on restricted share units 508,850   2,433,196   84,454 0 0
Interest and accretion on convertible debt       9,931 9,931 60,337 39,211
Total (5,571,824) (1,903,062) (15,589,442) (6,067,038) (9,809,503) (4,433,520) (915,318)
Changes in non-cash working capital items              
Accounts receivable (1,504,376) 218,432 (2,365,752) 327,776 (67,550) (496,545) (262,276)
Prepayments and deposits (2,668,131) (631,538) (7,118,905) (1,938,325) (633,824) (215,537) (114,538)
Inventory (719,231) (711) (1,322,927) (191,310) (133,438) (46,556) 0
Accounts payable and accrued liabilities 5,218,663 155,725 9,830,211 214,656 3,215,386 624,090 606,150
Total (5,244,899) (2,161,153) (16,566,815) (7,654,241) (7,428,929) (4,568,068) (685,982)
Investing activity              
Purchases of plant and equipment (5,298,447) (836,378) (12,066,848) (1,748,271) (5,107,663) (998,069) (244,276)
Proceeds from disposal of plant and equipment     16,866        
Net cash used in investing activities (5,298,447) (836,378) (12,049,982) (1,748,271)      
Financing activities              
Proceeds from share issuance, net of share issue costs     21,620,000 6,481,381 6,481,381 5,379,860 2,645,136
Proceeds from exercise of stock options 169,105   169,105        
Proceeds from loans payable 7,000,000 5,663 10,091,220 2,149,335 2,153,110 86,572 0
Proceeds from government grants 26,887 429,537 92,926 1,131,730 1,182,599 1,697,794 77,215
Proceeds from convertible debt         0 0 388,455
Repayment of lease liabilities (204,231) (137,173) (530,953) (250,371) (387,508) 0 0
Repayment of loans payable (423,595) (3,871) (1,138,336) (10,051) (12,881) 0 0
Net cash used in financing activities 6,568,166 294,156 30,303,962 9,502,024 9,416,701 7,164,226 3,110,806
Net change in cash (3,975,180) (2,703,375) 1,687,165 99,512 (3,119,891) 1,598,089 2,180,548
Cash, beginning of year 6,325,902 6,586,336 663,557 3,783,449 3,783,449 2,185,360 4,812
Cash, end of year 2,350,722 $ 3,882,961 2,350,722 3,882,961 663,557 3,783,449 2,185,360
Non-cash investing activities              
Accrual for purchase of plant and equipment $ 251,802   1,584,399        
Non-cash financing activities              
Equity issued for non-cash costs     $ 0 $ 947,464 $ 492,409 $ 118,759 $ 0